PhoreMost Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PhoreMost Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12354
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PhoreMost Ltd (PhoreMost) is a drug discovery company that develops drugs for the treatment of cancer. The company’s lead drug discovery program is based on a novel target, which tackles the undruggable cancer gene KRAS that affects various types of cancer. It develops Site-Seeker, a platform that systematically unmasks druggable sites in the human genome and links them to useful therapeutic functions in a live-cell context. PhoreMost’s Site Seeker platform differs from other genome-based target screening technologies. The company also provides drug discovery services to a network of co-invested academic and industrial collaboration partners. PhoreMost is headquartered in Cambridge, the UK.

PhoreMost Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PhoreMost Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PhoreMost Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PhoreMost Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PhoreMost Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PhoreMost Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PhoreMost Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
PhoreMost Raises USD15 Million in Series A Venture Financing 10
PhoreMost Raises USD3.8 Million in Seed Financing 12
Partnerships 13
PhoreMost Enters into Agreement with o2h discovery 13
PhoreMost Enters into Collaboration Agreement with Plexxikon 14
PhoreMost Enters into Research Agreement with University of Cambridge 15
PhoreMost Enters into Agreement with Wistar Institute 16
Licensing Agreements 17
Phylogica Enters into Licensing Agreement with PhoreMost 17
PhoreMost Ltd – Key Competitors 18
PhoreMost Ltd – Key Employees 19
PhoreMost Ltd – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Government and Public Interest 21
Jun 15, 2017: PhoreMost and Babraham Institute Awarded £0.6M Innovate UK Funding 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
PhoreMost Ltd, Pharmaceuticals & Healthcare, Key Facts 2
PhoreMost Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PhoreMost Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PhoreMost Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PhoreMost Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
PhoreMost Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PhoreMost Raises USD15 Million in Series A Venture Financing 10
PhoreMost Raises USD3.8 Million in Seed Financing 12
PhoreMost Enters into Agreement with o2h discovery 13
PhoreMost Enters into Collaboration Agreement with Plexxikon 14
PhoreMost Enters into Research Agreement with University of Cambridge 15
PhoreMost Enters into Agreement with Wistar Institute 16
Phylogica Enters into Licensing Agreement with PhoreMost 17
PhoreMost Ltd, Key Competitors 18
PhoreMost Ltd, Key Employees 19

List of Figures
PhoreMost Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PhoreMost Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PhoreMost Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PhoreMost Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PhoreMost Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PhoreMost Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PhoreMost Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PhoreMost Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PhoreMost Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Genentech, Inc.:戦略・SWOT・企業財務分析
    Genentech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genentech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • BiondVax Pharmaceuticals Ltd (BVXV):企業の財務・戦略的SWOT分析
    Summary BiondVax Pharmaceuticals Ltd (BiondVax Pharmaceuticals) is a biopharmaceutical company that develops universal flu vaccine. The company provides lead product M-001 is a synthetic peptide-based protein that offers protection against human influenza virus strains including seasonal influenza s …
  • WInckworth Sherwood LLP:企業の戦略的SWOT分析
    WInckworth Sherwood LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • STRATEC Biomedical AG (SBS):企業の財務・戦略的SWOT分析
    Summary STRATEC Biomedical AG (STRATEC), formerly Stratec Biomedical Systems AG is a medical equipment provider that develops and manufactures automated systems for clinical diagnostics. The company provides instrumentation, data management, molecular solutions, and others. It offers data management …
  • DTE Energy Co (DTE):石油・ガス:M&Aディール及び事業提携情報
    Summary DTE Energy Company (DTE Energy) is a diversified energy company that develops and manages energy-related businesses and services. It has presence in the electricity value chain from generation, procurement, to transmission, distribution, and sales. The company procures, stores, and transport …
  • Japan Vilene Company, Ltd.:戦略・SWOT・企業財務分析
    Japan Vilene Company, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Japan Vilene Company, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Photo-Me International plc (PHTM):企業の財務・戦略的SWOT分析
    Summary Photo-Me International plc (Photo-Me) is a consumer goods provider that offers photographic products. The company offers optical and instant service equipment. It operates a range of vending equipment such as self-service launderettes, digital printing kiosks, children rides and amusement ma …
  • South Egypt Drug Industries Co:企業の戦略的SWOT分析
    South Egypt Drug Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Amec Foster Wheeler plc (formerly AMEC plc):戦略・SWOT・企業財務分析
    Amec Foster Wheeler plc (formerly AMEC plc) - Strategy, SWOT and Corporate Finance Report Summary Amec Foster Wheeler plc (formerly AMEC plc) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Navayuga Infotech Pvt. Ltd.:企業の戦略的SWOT分析
    Navayuga Infotech Pvt. Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Schweiter Technologies AG (SWTQ):企業の財務・戦略的SWOT分析
    Summary Schweiter Technologies AG (Schweiter) is a technology company that develops, manufactures and commercialize composite panels and core materials for sandwich constructions. The company’s business category includes core materials, architecture, display and transportation. It SSM textile machin …
  • Sir Robert McAlpine Ltd:企業の戦略的SWOT分析
    Sir Robert McAlpine Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Barco N.V.:企業の戦略・SWOT・財務情報
    Barco N.V. - Strategy, SWOT and Corporate Finance Report Summary Barco N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • A.P. Moller – Maersk AS (MAERSK B):石油・ガス:M&Aディール及び事業提携情報
    Summary A.P. Moller - Maersk AS (APM) is an integrated transport and logistics company with operations in container shipping and ports operating through a subsidiary and affiliates. It transports dry cargo, refrigerated cargo, special cargo and also conducts used container sales and supports intermo …
  • BAM Nuttall Ltd:企業の戦略的SWOT分析
    BAM Nuttall Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Panacea Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Panacea Pharmaceuticals Inc (Panacea) is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutic and diagnostic products for the treatment of cancer and central nervous system diseases. The company’s pipeline products include PAN-301-1, a human aspa …
  • The Yokohama Rubber Co., Ltd.:企業の戦略・SWOT・財務情報
    The Yokohama Rubber Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Yokohama Rubber Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Port of Rotterdam Authority NV:企業の戦略的SWOT分析
    Port of Rotterdam Authority NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • SandRidge Energy Inc (SD):石油・ガス:M&Aディール及び事業提携情報
    Summary SandRidge Energy Inc (SandRidge) is an upstream energy company. It develops, explores for, and produces oil and natural gas in the Mid-Continent and Rockies regions of the US. In Mid-Continent, the company operates assets in Oklahoma and Kansas. In Rockies, SandRidge operates assets within t …
  • Nippon Chemiphar Co Ltd (4539):企業の財務・戦略的SWOT分析
    Summary Nippon Chemiphar Co Ltd (Nippon Chemiphar) is a provider of pharmaceutical drugs and health-related services. The company manufactures, supplies, imports and exports ethical pharmaceuticals and diagnostic agents. Nippon Chemiphar offers diagnostic products, such as IgE NC, a diagnostic kit t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆